Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast

Allergy and Asthma Proceedings

Volumn 32, Issue 6, 2011, Pages 453-459

  Wasfi, Yasmine S ^a   Kemp, James P ^b   Villarán, César ^c   Massaad, Rachid ^a   Xin, Wenjing ^a   Smugar, Steven S ^a   Knorr, Barbara A ^a   Philip, George ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLÍNICA RICARDO PALMA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST; PLACEBO;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BRONCHOSPASM; CHILD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; EXERCISE INDUCED BRONCHOCONSTRICTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT;

ACETATES; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; CHILD; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; QUINOLINES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 84355167606     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3482     Document Type: Article

References (20)

1. Lang DM, Butz AM, Duggan AK, et al. Physical activity in urban school-aged children with asthma. Pediatrics 113:e341-e346, 2004.
2. Milgrom H, and Taussig LM. Keeping children with exerciseinduced asthma active. Pediatrics 104:e38, 1999.
3. National Heart, Lung, and Blood (NHLB) Institute. Expert panel report: Guidelines for the diagnosis and management of asthma (EPR 2007). NIH Publication No. 08-4051, U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program, Bethesda, MD, 2008.
4. McFadden ER Jr, and Gilbert IA. Exercise-induced asthma. N Engl J Med 330:1362-1367, 1994. (Pubitemid 24136061)
5. Pearlman DS, van Adelsberg J, Philip G, et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 97:98-104, 2006. (Pubitemid 44156345)
6. Philip G, Villaran C, Pearlman DS, et al. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 44:213-217, 2007. (Pubitemid 46598156)
7. Philip G, Pearlman DS, Villaran C, et al. Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest 132:875-883, 2007.
8. Fogel RB, Rosario N, Aristizabal G, et al. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 104:511-517, 2010.
9. Kemp JP, Dockhorn RJ, Shapiro GG, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 133:424-428, 1998. (Pubitemid 28413629)
10. Peroni DG, Piacentini GL, Pietrobelli A, et al. The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children. Eur Respir J 20:104-107, 2002. (Pubitemid 34822929)
11. Peroni DG, Piacentini GL, Ress M, et al. Time efficacy of a single dose of montelukast on exercise-induced asthma in children. Pediatr Allergy Immunol 13:434-437, 2002. (Pubitemid 36069955)
12. Center for Drug Evaluation and Research. Guidance for Industry. Exercise-Induced Bronchospasm (EIB)-Development of Drugs to Prevent EIB. Food and Drug Administration, Rockville, MD, 2002.
13. Godfrey S, and Silverman M. Demonstration by placebo response in asthma by means of exercise testing. J Psychosom Res 17:293-297, 1973.
14. Boner AL, Vallone G, Peroni DG, et al. Efficacy and duration of action of placebo responses in the prevention of exercise-induced asthma in children. J Asthma 25:1-5, 1988.
15. Kemeny ME, Rosenwasser LJ, Panettieri RA, et al. Placebo response in asthma: A robust and objective phenomenon. J Allergy Clin Immunol 119:1375-1381, 2007. (Pubitemid 46855863)
16. Bonini S, Brusasco V, Carlsen KH, et al. Diagnosis of asthma and permitted use of inhaled beta2-agonists in athletes. Allergy 59:33-36, 2004. (Pubitemid 38167948)
17. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161:309-329, 2000.
18. Helenius I, Lumme A and Haahtela T. Asthma, airway inflammation and treatment in elite athletes. Sports Med 35:565-574, 2005. (Pubitemid 41239991)
19. Joos GF, O'Connor B, Anderson SD, et al. Indirect airway challenges. Eur Respir J 21:1050-1068, 2003. (Pubitemid 36675625)
20. Philip G, Swern AS, Smugar SS, et al. Baseline predictors of placebo response in exercise-induced bronchoconstriction (EIB): Pooled regression analysis from three studies of montelukast in EIB. J Asthma 47:935-941, 2010.